7-甲氧基-2-三氟甲基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺 | 1009601-54-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并吡啶类
• 中文名称: 7-甲氧基-2-三氟甲基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺
• 英文名称: 7-methoxy-2-trifluoromethylpyrazolo[1,5-a]pyridine-4-carboxylic acid (3,5-dichloro pyridin-4-yl)amide
• 英文别名: 7-methoxy-2-trifluoromethylpyrazolo[1,5-a]pyridine-4-carboxylic acid (3,5-dichloropyridin-4-yl)amide；N-(3,5-dichloropyridin-4-yl)-7-methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine-4-carboxamide
• CAS: 1009601-54-0
• 化学式: C₁₅H₉Cl₂F₃N₄O₂
• 分子量: 405.163
• InChiKey: VHYJJZZCHUGEDB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  68.5
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  7-甲氧基-2-三氟甲基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺 在 溶剂黄146 、 间氯过氧苯甲酸 、 水 、 potassium carbonate 作用下， 以 二氯甲烷 为溶剂， 反应 96.0h， 生成 3-羟基-7-甲氧基-2-三氟甲基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺
  参考文献：
  名称：

  EP2058310

  摘要：

  公开号：
• 作为产物：
  描述：

  (6-甲氧基吡啶-3-基)甲醇 在 4-二甲氨基吡啶 、 manganese(IV) oxide 、 sodium chlorite 、 2-甲基-2-丁烯 、 sodium dihydrogenphosphate dihydrate 、 2,4,6-三甲基苯磺酰羟胺 、 sodium hydride 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 、 邻二氯苯 、 叔丁醇 为溶剂， 反应 34.5h， 生成 7-甲氧基-2-三氟甲基吡唑并[1,5-a]吡啶-4-羧酸(3,5-二氯吡啶-4-基)酰胺
  参考文献：
  名称：

  Phosphodiesterase inhibitors. Part 6: Design, synthesis, and structure–activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity

  摘要：

  We previously identified KCA-1490 [(-)-6-(7-methoxy-2-trifluoromethyl-pyrazolo[1,5-alpha] pyridin-4-yl)-5- methyl-4,5-dihydro-3-(2H)-pyridazinone], a dual PDE3/4 inhibitor. In the present study, we found highly potent selective PDE4 inhibitors derived from the structure of KCA-1490. Among them, N-(3,5-dichloropyridin-4-yl)-7-methoxy-2-(trifluoromethyl) pyrazolo[1,5-alpha] pyridine-4-carboxamide (2 alpha) had good anti-inflammatory effects in an animal model. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.07.069

文献信息

• Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
  申请人：Kohno Yasushi

  公开号：US20100056791A1

  公开（公告）日：2010-03-04

  A novel pyrazolopyridine carboxamide derivative is provided that is useful as a pharmaceutical drug having phosphodiesterase inhibitory activity. The pyrazolopyridine carboxamide derivative is represented by the following general formula (1): (Example: 2-ethyl-7-methoxypyrazolo[1,5-a]pyridine-4-carboxylic acid (3,5-dichloropyridin-4-yl)amide).

  提供了一种新型的吡唑吡啶羧酰胺衍生物，其可用作具有磷酸二酯酶抑制活性的药物。该吡唑吡啶羧酰胺衍生物由以下通式（1）表示：（例如：2-乙基-7-甲氧基吡唑并[1,5-a]吡啶-4-羧酸（3,5-二氯吡啶-4-基）酰胺）。
• COMPOSITIONS AND METHODS FOR THE TREATMENT OF JUVENILE NEURONAL CEROID LIPOFUSCINOSIS AND RELATED DISORDERS
  申请人：BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

  公开号：US20140121166A1

  公开（公告）日：2014-05-01

  Provided are materials and methods for the prevention and treatment of Juvenile Neuronal Ceroid Lipofuscinosis comprising administration of an effective amount of at least one of a hemi-channel inhibitor or a phosphodiesterase-4 inhibitor. In some embodiments, the methods comprise administration of an effective amount of each of a hemi-channel inhibitor and a phosphodiesterase-4 inhibitor. Also provided are pharmaceutical compositions comprising a hemi-channel inhibitor or a phosphodiesterase-4 inhibitor, as well as kits comprising at least one effective dose of a hemi-channel inhibitor or a phosphodiesterase-4 inhibitor or a combination of both.
• TREATMENT OF INFLAMMATORY DISEASE USING INGESTIBLE DEVICE TO RELEASE IMMUNE MODULATOR
  申请人：Progenity, Inc.

  公开号：US20200323772A1

  公开（公告）日：2020-10-15

  This disclosure features methods and compositions for treating inflammatory disorders or conditions that arise in a tissue originating from the endoderm using an immune modulator.
• TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A PDE4 INHIBITOR
  申请人：Progenity, Inc.

  公开号：US20210031012A1

  公开（公告）日：2021-02-04

  This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a PDE4 inhibitor.
• US9457030B2
  申请人：——

  公开号：US9457030B2

  公开（公告）日：2016-10-04